R.H. Bluestein & Co’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $308K | Sell |
3,529
-225
| -6% | -$20.4K | 0.02% | 239 |
|
|
2022
Q2 | $293K | Buy |
3,754
+225
| +6% | +$18.6K | 0.02% | 254 |
|
|
2022
Q1 | $301K | Sell |
3,529
-154,003
| -98% | -$14.8M | 0.01% | 290 |
|
|
2021
Q4 | $18.9M | Buy |
157,532
+38,210
| +32% | +$4.74M | 0.68% | 42 |
|
|
2021
Q3 | $14.8M | Buy |
119,322
+104,722
| +717% | +$13.5M | 0.58% | 39 |
|
|
2021
Q2 | $1.75M | Buy |
14,600
+11,100
| +317% | +$1.27M | 0.07% | 79 |
|
|
2021
Q1 | $368K | Hold |
3,500
| – | – | 0.02% | 267 |
|
|
2020
Q4 | $356K | Hold |
3,500
| – | – | 0.02% | 246 |
|
|
2020
Q3 | $294K | Hold |
3,500
| – | – | 0.01% | 251 |
|
|
2020
Q2 | $227K | Hold |
3,500
| – | – | 0.01% | 292 |
|
|
2020
Q1 | $228K | Sell |
3,500
-1,500
| -30% | -$118K | 0.02% | 229 |
|
|
2019
Q4 | $394K | Hold |
5,000
| – | – | 0.02% | 203 |
|
|
2019
Q3 | $398K | Hold |
5,000
| – | – | 0.02% | 179 |
|
|
2019
Q2 | $418K | Sell |
5,000
-800
| -14% | -$63.7K | 0.02% | 172 |
|
|
2019
Q1 | $458K | Sell |
5,800
-2,000
| -26% | -$146K | 0.03% | 142 |
|
|
2018
Q4 | $520K | Sell |
7,800
-311,528
| -98% | -$21.6M | 0.04% | 104 |
|
|
2018
Q3 | $25.5M | Buy |
319,328
+45,765
| +17% | +$3.42M | 1.23% | 36 |
|
|
2018
Q2 | $18.4M | Buy |
273,563
+104,245
| +62% | +$7.57M | 0.95% | 40 |
|
|
2018
Q1 | $13M | Buy |
169,318
+154,918
| +1,076% | +$11.5M | 0.71% | 43 |
|
|
2017
Q4 | $982K | Sell |
14,400
-14,350
| -50% | -$953K | 0.05% | 82 |
|
|
2017
Q3 | $1.8M | Buy |
28,750
+18,650
| +185% | +$1.11M | 0.1% | 58 |
|
|
2017
Q2 | $560K | Buy |
10,100
+100
| +1% | +$5.21K | 0.03% | 125 |
|
|
2017
Q1 | $502K | Sell |
10,000
-2,014
| -17% | -$98.2K | 0.03% | 134 |
|
|
2016
Q4 | $595K | Buy |
12,014
+2,014
| +20% | +$102K | 0.04% | 110 |
|
|
2016
Q3 | $525K | Hold |
10,000
| – | – | 0.03% | 104 |
|
|
2016
Q2 | $447K | Sell |
10,000
-1,000
| -9% | -$43.5K | 0.03% | 109 |
|
|
2016
Q1 | $450K | Buy |
11,000
+1,000
| +10% | +$36.8K | 0.03% | 132 |
|
|
2015
Q4 | $365K | Hold |
10,000
| – | – | 0.02% | 174 |
|
|
2015
Q3 | $329K | Sell |
10,000
-5
| -0% | -$168 | 0.02% | 206 |
|
|
2015
Q2 | $371K | Sell |
10,005
-400
| -4% | -$14.6K | 0.02% | 217 |
|
|
2015
Q1 | $364K | Sell |
10,405
-411,674
| -98% | -$14.5M | 0.02% | 224 |
|
|
2014
Q4 | $16.1M | Sell |
422,079
-48
| -0% | -$1.76K | 1.01% | 39 |
|
|
2014
Q3 | $15M | Buy |
422,127
+3,665
| +0.9% | +$136K | 0.94% | 44 |
|
|
2014
Q2 | $16.4M | Buy |
418,462
+19,740
| +5% | +$738K | 0.97% | 44 |
|
|
2014
Q1 | $14.5M | Buy |
398,722
+338,472
| +562% | +$12.3M | 0.96% | 43 |
|
|
2013
Q4 | $2.08M | Buy |
60,250
+42,800
| +245% | +$1.38M | 0.13% | 67 |
|
|
2013
Q3 | $487K | Sell |
17,450
-4,900
| -22% | -$131K | 0.03% | 184 |
|
|
2013
Q2 | $602K | Buy |
+22,350
| New | +$617K | 0.05% | 149 |
|
Other funds holding XYL
PAMS
R.H. Bluestein & Co's XYL Position: Q3 2022 in Review
R.H. Bluestein & Co reduced its Xylem (XYL) stake by 6% in Q3 2022, selling an estimated $20.4K and leaving 3,529 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #239.
R.H. Bluestein & Co first reported a position in XYL in Q2 2013 and has held it in 38 quarters since. The position peaked at $25.5M in Q3 2018. 740 funds tracked by Wall St. Rank hold XYL as of Q3 2022.
- R.H. Bluestein & Co held 3,529 shares of Xylem worth $308K as of Q3 2022.
- R.H. Bluestein & Co sold 225 Xylem shares in Q3 2022, an estimated $20.4K.
- Xylem made up 0.02% of R.H. Bluestein & Co's portfolio in Q3 2022, its #239 holding.
- R.H. Bluestein & Co first reported a position in Xylem in Q2 2013 and has held it in 38 quarters since.
- R.H. Bluestein & Co's Xylem position peaked at $25.5M in Q3 2018.
- 740 funds tracked by Wall St. Rank held Xylem as of Q3 2022.
Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.